Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06665906 · ClinicalTrials.gov registry record · NA

Using a Patient Navigator to Address the Social Drivers of Health in the Management of Pain

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT06665906: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT06665906 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06665906, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The purpose of this study is to see if patients with chronic pain can improve how they manage their pain and daily function by working with a care manager and by learning pain coping skills from an online teaching tool.

Primary Outcome

Mean number of participants recruited each month. Formula for calculation is planned number of enrolled and randomized participants (30) divided by total number of months needed to recruit 30 participants. The higher the number, the faster the recruitment is (i.e., 30 participants divided by 15 months = 2 per month).

Interventions

  • BEHAVIORAL Web-Based Cognitive Behavioral Therapy (PainTrainer)
  • BEHAVIORAL Social Intervention

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2024-11-19
Est. Completion 2025-10-07
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT06665906 record still lists

NCT06665906 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Web-Based Cognitive Behavioral Therapy (PainTrainer) is the first listed.

NCT06665906 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06665906 about?

NCT06665906 is a clinical study titled "Using a Patient Navigator to Address the Social Drivers of Health in the Management of Pain". The purpose of this study is to see if patients with chronic pain can improve how they manage their pain and daily function by working with a care manager and by learning pain coping skills from an online teaching tool.

What is the current status of trial NCT06665906?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2024-11-19. Estimated completion is 2025-10-07.

What interventions are being tested in trial NCT06665906?

The interventions under investigation include: Web-Based Cognitive Behavioral Therapy (PainTrainer) (BEHAVIORAL), Social Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06665906?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06665906's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06665906, the US trial registry maintained by the National Library of Medicine. NCT06665906 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.